B of A Securities Maintains Option Care Health (OPCH) Buy Recommendation

BofA Securities kept a Buy on Option Care Health on Dec. 9, 2025, with an average one-year price target of $35.70 implying about 16.7% upside from the $30.59 close (range $27.27–$42.00). Analysts project 2025 revenue of $5,118m (down 7.5%) and non‑GAAP EPS of $1.12; options sentiment is mildly bullish with a put/call ratio of 0.51. Institutional ownership remains broad—856 funds hold the name with total institutional shares down ~1.1% to roughly 203.4m and average portfolio weight rising to 0.23%—while large holders such as Wellington and Durable trimmed positions and Fuller & Thaler increased exposure, signaling mixed but generally constructive investor interest.

Analysis

BofA Securities maintained a Buy on Option Care Health (OPCH) on December 9, 2025, and the consensus one-year price target of $35.70 (as of Dec. 6) implies approximately 16.7% upside from the $30.59 close; analyst targets range from $27.27 to $42.00, indicating dispersed views. Options sentiment is mildly bullish with a put/call ratio of 0.51 and the aggregated sentiment score at 0.28, suggesting constructive near-term positioning by derivatives traders.

Company fundamentals in the data snapshot are mixed: projected annual revenue of $5,118 million represents a 7.46% decline, while projected non-GAAP EPS is $1.12, creating a risk that top-line weakness could pressure forward multiple expansion despite the analyst upgrade. Institutional ownership is broad but subtly shifting — 856 funds hold the name, total institutional shares fell ~1.08% to 203.385 million, and average portfolio weight rose to 0.23%, reflecting portfolio rebalancing rather than unanimous conviction.

Major holders show dispersion: Wellington and Durable Capital trimmed positions quarter-over-quarter while Fuller & Thaler increased exposure; these directional reallocations and the modest market-impact score (0.3) imply the stock is sensitive to further earnings or filing updates. The net picture is a buy-rated security with quantifiable upside but tangible execution and revenue risks that merit position sizing and active monitoring.

Key Decisions for Investors

• Consider a modest buy/overweight position to capture the ~16.7% analyst-implied upside, but keep position sizing conservative given the projected 7.5% revenue decline
• Monitor the next quarterly revenue and non-GAAP EPS prints closely and be prepared to trim or hedge if results undershoot the $5,118m revenue projection or the $1.12 EPS expectation
• Track institutional 13F activity from large holders (Wellington, Durable, Fuller & Thaler) for directional signals; continued trimming by multiple large owners should prompt re-evaluation of exposure
• If seeking upside with defined risk, consider using bullish option structures (e.g., vertical call spreads) rather than outright long calls, noting the put/call ratio of 0.51 signals mild bullish options sentiment